retinoid X receptor partial agonist (Okayama University)

N/A

Report date: 2025/03/20 14:44:04
NME

Base Information

Drug Nameretinoid X receptor partial agonist (Okayama University)
Drug Alias NameNEt-4IB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor modulators
TargetsRetinoid X receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2PsoriasisAsthma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOkayama University
China Registration ClassN/A

Develop Information

Active CompaniesOkayama University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2PsoriasisAsthma +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A